A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation

References

• Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74. doi:https://doi.org/10.1038/s41572-020-0205-x.
   PubMed Web of Science ®Google Scholar
• Ray G, Longworth MS. Epigenetics, DNA Organization, and inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:235–28. doi:10.1093/ibd/izy330.
   PubMed Web of Science ®Google Scholar
• de Souza HSP, Fiocchi C, de Souza HSP. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13(1):13–27. doi:https://doi.org/10.1038/nrgastro.2015.186.
   PubMed Web of Science ®Google Scholar
• Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606–1619. doi:https://doi.org/10.1016/s0140-6736(12)60150-0.
   PubMed Web of Science ®Google Scholar
• Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020;180:114147. doi:10.1016/j.bcp.2020.114147.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012;61(11):1619–1635. doi:https://doi.org/10.1136/gutjnl-2012-302830.
   PubMed Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, deRoos P, Liu H, Cross JR, Pfeffer K. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–455. doi:https://doi.org/10.1038/nature12726.
   PubMed Web of Science ®Google Scholar
• Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson K, Glover L, Kominsky D, Magnuson A. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17(5):662–671. doi:https://doi.org/10.1016/j.chom.2015.03.005.
   PubMed Web of Science ®Google Scholar
• Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014;111:2247–2252. doi:10.1073/pnas.1322269111.
   PubMed Web of Science ®Google Scholar
• O’Keefe SJD. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 2016;13(12):691–706. doi:https://doi.org/10.1038/nrgastro.2016.165.
   PubMed Web of Science ®Google Scholar
• Ferrer-Picón E, Dotti I, Corraliza AM, Mayorgas A, Esteller M, Perales JC, Ricart E, Masamunt MC, Carrasco A, Tristán E. et al. Intestinal inflammation modulates the epithelial response to butyrate in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2020;26(1):43–55. doi:https://doi.org/10.1093/ibd/izz119.
   PubMed Web of Science ®Google Scholar
• Gill PA, van Zelm MC, Muir JG, Gibson PR. Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment Pharmacol Ther. 2018;48(1):15–34. doi:https://doi.org/10.1111/apt.14689.
   PubMed Web of Science ®Google Scholar
• Pituch A, Walkowiak J, Banaszkiewicz A. Butyric acid in functional constipation. Prz Gastroenterol. 2013;8:295–298. doi:10.5114/pg.2013.38731.
   PubMedGoogle Scholar
• Wang L, Cheng X, Bai L, Gao M, Kang G, Cao X, Huang H. Positive interventional effect of engineered butyrate-producing bacteria on metabolic disorders and intestinal flora disruption in obese mice. Microbiol Spectr. 2022;10(2):e01147–21. doi:https://doi.org/10.1128/spectrum.01147-21.
   PubMed Web of Science ®Google Scholar
• Belenguer A, Duncan Sylvia H, Calder AG, Holtrop G, Louis P, Lobley Gerald E, Flint HJ. Two routes of metabolic cross-feeding between bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 2006;72(5):3593–3599. doi:https://doi.org/10.1128/AEM.72.5.3593-3599.2006.
   PubMed Web of Science ®Google Scholar
• Wang H, Cui B, Li Q, Ding X, Li P, Zhang T, Yang X, Ji G, Zhang F. The safety of fecal microbiota transplantation for Crohn’s disease: findings from a long-term study. Adv Ther. 2018;35(11):1935–1944. doi:https://doi.org/10.1007/s12325-018-0800-3.
   PubMed Web of Science ®Google Scholar
• Chen X, Gao M, Wang L, Qiang G, Wu Y, Huang H, Kang G. A synthetic microbial consortium protects against obesity by regulating vitamin B6 metabolism. Gut Microbes. 2024;16(1):1. doi:https://doi.org/10.1080/19490976.2024.2304901.
   Web of Science ®Google Scholar
• Pineiro M, Stanton C. Probiotic bacteria: legislative framework—requirements to evidence Basis1,2. J Nutr. 2007;137(3):850S–853S. doi:10.1093/jn/137.3.850S.
   PubMed Web of Science ®Google Scholar
• Barbosa RSD, Vieira-Coelho MA. Probiotics and prebiotics: focus on psychiatric disorders – a systematic review. Nutr Rev. 2020;78(6):437–450. doi:https://doi.org/10.1093/nutrit/nuz080.
   PubMed Web of Science ®Google Scholar
• Chapman CMC, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr. 2011;50(1):1–17. doi:https://doi.org/10.1007/s00394-010-0166-z.
   PubMed Web of Science ®Google Scholar
• Duan FF, Liu JH, March JC. Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes. 2015;64(5):1794–1803. doi:https://doi.org/10.2337/db14-0635.
   PubMed Web of Science ®Google Scholar
• Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol. 2007;297(3):151–162. doi:10.1016/j.ijmm.2007.01.008.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Y, Xia L, Zhang X, Ding X, Yan F, Wu F. Escherichia coli nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of Azurin protein. Appl Environ Microbiol. 2012;78(21):7603–7610. doi:https://doi.org/10.1128/AEM.01390-12.
   PubMed Web of Science ®Google Scholar
• Jouhten P, Boruta T, Andrejev S, Pereira F, Rocha I, Patil KR. Yeast metabolic chassis designs for diverse biotechnological products. Sci Rep. 2016;6(1):9. doi:https://doi.org/10.1038/srep29694.
   PubMedGoogle Scholar
• Lian JZ, Mishra S, Zhao HM. Recent advances in metabolic engineering of Saccharomyces cerevisiae: new tools and their applications. Metab Eng. 2018;50:85–108. doi:10.1016/j.ymben.2018.04.011.
   PubMed Web of Science ®Google Scholar
• Thak EJ, Yoo SJ, Moon HY, Kang HA. Yeast synthetic biology for designed cell factories producing secretory recombinant proteins. FEMS Yeast Res. 2020;20(2):17. doi:https://doi.org/10.1093/femsyr/foaa009.
   Web of Science ®Google Scholar
• Scott BM, Gutiérrez-Vázquez C, Sanmarco LM, da Silva Pereira JA, Li Z, Plasencia A, Hewson P, Cox LM, O’Brien M, Chen SK. et al. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease. Nat Med. 2021;27(7):1212–1222. doi:https://doi.org/10.1038/s41591-021-01390-x.
   PubMed Web of Science ®Google Scholar
• Sun S, Xu X, Liang L, Wang X, Bai X, Zhu L, He Q, Liang H, Xin X, Wang L. et al. Lactic acid-producing probiotic Saccharomyces cerevisiae attenuates ulcerative colitis via suppressing macrophage pyroptosis and modulating gut microbiota. Front Immunol. 2021;12:777665. doi:10.3389/fimmu.2021.777665.
   PubMed Web of Science ®Google Scholar
• Lee JY, Tsolis RM, Bäumler AJ. The microbiome and gut homeostasis. Science. 2022;377(6601):eabp9960. doi:https://doi.org/10.1126/science.abp9960.
   PubMed Web of Science ®Google Scholar
• Cueno ME, Kamio N, Seki K, Kurita-Ochiai T, Ochiai K. High butyric acid amounts induce oxidative stress, alter calcium homeostasis, and cause neurite retraction in nerve growth factor-treated PC12 cells. Cell Stress Chaperones. 2015;20(4):709–713. doi:https://doi.org/10.1007/s12192-015-0584-1.
   PubMed Web of Science ®Google Scholar
• Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastro Hepat. 2020;17(4):223–237. doi:https://doi.org/10.1038/s41575-019-0258-z.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:https://doi.org/10.1038/s41586-019-1237-9.
   PubMed Web of Science ®Google Scholar
• Wang RQ, Yang XY, Liu JT, Zhong F, Zhang C, Chen YH, Sun T, Ji C, Ma D. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun. 2022;13(1):13. doi:https://doi.org/10.1038/s41467-022-30240-8.
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Holley D, Collins LB, Montgomery SA, Whitmore AC, Hillhouse A, Curry KP, Renner SW, Greenwalt A, Ryan EP. et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 2014;4(12):1387–1397. doi:https://doi.org/10.1158/2159-8290.Cd-14-0501.
   PubMed Web of Science ®Google Scholar
• Sun J, Xu JX, Yang B, Chen KY, Kong Y, Fang N, Gong, T, Wang F, Ling, Z, Liu, J, et al. Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer’s Disease via Regulating Gut Microbiota and Metabolites Butyrate. Mol Nutr Food Res. 2020:64. doi:10.1002/mnfr.201900636
   Web of Science ®Google Scholar
• Chen RZ, Xu Y, Wu P, Zhou H, Lasanajak Y, Fang YY, Tang, Lan, Ye, Ling, Li, Xing, Cai, Z, et al. Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota. Pharmacological Research. 2019; 148. 10.1016/j.phrs.2019.104403.
   Web of Science ®Google Scholar
• Bell KJ, Saad S, Tillett BJ, McGuire HM, Bordbar S, Yap YA, Nguyen LT, Wilkins MR, Corley S, Brodie S. et al. Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome. 2022;10(1):10. doi:https://doi.org/10.1186/s40168-021-01193-9.
   PubMed Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan XY, Dikiy S, van der Veeken J, deRoos P, deRoos P, Liu H, Cross JR, Pfeffer K. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–455. doi:10.1038/nature12726.
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012;48(4):612–626. doi:https://doi.org/10.1016/j.molcel.2012.08.033.
   PubMed Web of Science ®Google Scholar
• Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C. The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line. Gastroenterology. 2000;118(4):724–734. doi:https://doi.org/10.1016/s0016-5085(00)70142-9.
   PubMed Web of Science ®Google Scholar
• Segain JP, de la Blétière DR, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier, L, Bonnet, C, Blottiere, H, Galmiche, J. Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn’s disease. Gut. 2000;47(3):397–403. doi:10.1136/gut.47.3.397.
   PubMed Web of Science ®Google Scholar
• Kim MH, Kang SG, Park JH, Yanagisawa M, Kim CH. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. 2013;145(2):396–406.e10. doi:10.1053/j.gastro.2013.04.056.
   PubMed Web of Science ®Google Scholar
• Yang WJ, Yu TM, Huang XS, Bilotta AJ, Xu LQ, Lu Y, Sun J, Pan F, Zhou J, Zhang W. et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):11. doi:https://doi.org/10.1038/s41467-020-18262-6.
   PubMed Web of Science ®Google Scholar
• Li YJ, Chen XC, Kwan TK, Loh YW, Singer J, Liu YZ, Ma J, Tan J, Macia L, Mackay CR. et al. Dietary fiber protects against diabetic nephropathy through short-chain fatty acid–mediated activation of G protein–coupled receptors GPR43 and GPR109A. J Am Soc Nephrol. 2020;31(6):1267–1281. doi:10.1681/asn.2019101029.
   PubMed Web of Science ®Google Scholar
• Steen EJ, Chan R, Prasad N, Myers S, Petzold CJ, Redding A, Ouellet M, Keasling JD. Metabolic engineering of Saccharomyces cerevisiae for the production of n-butanol. Microb Cell Fact. 2008;7(1):8. doi:https://doi.org/10.1186/1475-2859-7-36.
   PubMedGoogle Scholar
• Shen CR, Lan EI, Dekishima Y, Baez A, Cho KM, Liao JC. Driving forces enable high-titer anaerobic 1-butanol synthesis in Escherichia coli. Appl Environ Microbiol. 2011;77(9):2905–2915. doi:https://doi.org/10.1128/aem.03034-10.
   PubMed Web of Science ®Google Scholar
• Saini M, Chen MH, Chung-Jen C, Chao YP. Potential production platform of n-butanol in Escherichia coli. Metab Eng. 2015;27:76–82. doi:10.1016/j.ymben.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Louis P, Duncan SH, McCrae SI, Millar J, Jackson MS, Flint HJ. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol. 2004;186(7):2099–2106. doi:https://doi.org/10.1128/jb.186.7.2099-2106.2004.
   PubMed Web of Science ®Google Scholar
• Duncan SH, Hold GL, Harmsen HJM, Stewart CS, Flint HJ. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol. 2002;52(6):2141–2146. doi:10.1099/ijs.0.02241-0.
   PubMedGoogle Scholar
• Chen Y, Daviet L, Schalk M, Siewers V, Nielsen J. Establishing a platform cell factory through engineering of yeast acetyl-CoA metabolism. Metab Eng. 2013;15:48–54. doi:10.1016/j.ymben.2012.11.002.
   PubMed Web of Science ®Google Scholar
• Cheon Y, Kim JS, Park JB, Heo P, Lim JH, Jung GY, Seo J-H, Park JH, Koo HM, Cho KM. et al. A biosynthetic pathway for hexanoic acid production in Kluyveromyces marxianus. J Biotechnol. 2014;182:30–36. doi:10.1016/j.jbiotec.2014.04.010.
   PubMed Web of Science ®Google Scholar
• Chen Y, Siewers V, Nielsen J, Cobine P. Profiling of cytosolic and peroxisomal acetyl-CoA metabolism in Saccharomyces cerevisiae. PloS One. 2012;7(8):e42475. doi:https://doi.org/10.1371/journal.pone.0042475.
   PubMed Web of Science ®Google Scholar
• Li SY, Fu WX, Su RF, Zhao YY, Deng Y. Metabolic engineering of the malonyl-CoA pathway to efficiently produce malonate in Saccharomyces cerevisiae. Metab Eng. 2022;73:1–10. doi:10.1016/j.ymben.2022.05.007.
   PubMed Web of Science ®Google Scholar
• Takahashi H, McCaffery JM, Irizarry RA, Boeke JD. Nucleocytosolic acetyl-coenzyme A synthetase is required for histone acetylation and global transcription. Mol Cell. 2006;23(2):207–217. doi:https://doi.org/10.1016/j.molcel.2006.05.040.
   PubMed Web of Science ®Google Scholar
• Orlandi I, Casatta N, Vai M. Lack of Ach1 CoA-transferase triggers apoptosis and decreases chronological lifespan in yeast. Front Oncol. 2012;2:67. doi:10.3389/fonc.2012.00067.
   PubMedGoogle Scholar
• Hartig A, Simon MM, Schuster T, Daugherty JR, Yoo HS, Cooper TG. Differentially regulated malate synthase genes participate in carbon and nitrogen metabolism of S. cerevisiae. Nucleic Acids Res. 1992;20(21):5677–5686. doi:https://doi.org/10.1093/nar/20.21.5677.
   PubMed Web of Science ®Google Scholar
• Branduardi P, Longo V, Berterame NM, Rossi G, Porro D. A novel pathway to produce butanol and isobutanol in Saccharomyces cerevisiae. Biotechnol Biofuels. 2013;6(1):12. doi:https://doi.org/10.1186/1754-6834-6-68.
   PubMedGoogle Scholar
• Fleck CB, Brock M. Re-characterisation of Saccharomyces cerevisiae Ach1p: fungal CoA-transferases are involved in acetic acid detoxification. Fungal Genet Biol. 2009;46:473–485. doi:10.1016/j.fgb.2009.03.004.
   PubMed Web of Science ®Google Scholar
• Kim S, Hahn JS. Efficient production of 2,3-butanediol in Saccharomyces cerevisiae by eliminating ethanol and glycerol production and redox rebalancing. Metab Eng. 2015;31:94–101. doi:10.1016/j.ymben.2015.07.006.
   PubMed Web of Science ®Google Scholar
• Wakashima T, Abe K, Kihara A. Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation. J Biol Chem. 2014;289(36):24736–24748. doi:https://doi.org/10.1074/jbc.M114.571869.
   PubMed Web of Science ®Google Scholar
• Schadeweg V, Boles E. Increasing n-butanol production with Saccharomyces cerevisiae by optimizing acetyl-CoA synthesis, NADH levels and trans-2-enoyl-CoA reductase expression. Biotechnol Biofuels. 2016;9(1):11. doi:https://doi.org/10.1186/s13068-016-0673-0.
   PubMedGoogle Scholar
• Albertyn J, Hohmann S, Thevelein JM, Prior BA. GPD1, which encodes glycerol-3-phosphate dehydrogenase, is essential for growth under osmotic stress in Saccharomyces cerevisiae, and its expression is regulated by the high-osmolarity glycerol response pathway. Mol Cell Biol. 1994;14(6):4135–4144. doi:10.1128/mcb.14.6.4135.
   PubMed Web of Science ®Google Scholar
• Tehlivets O, Scheuringer K, Kohlwein SD. Fatty acid synthesis and elongation in yeast. Biochim Biophys Acta Mol Cell Biol Lipids. 2007;1771(3):255–270. doi:10.1016/j.bbalip.2006.07.004.
   PubMed Web of Science ®Google Scholar
• Leber C, Poison B, Fernandez-Moya R, Da Silva NA. Overproduction and secretion of free fatty acids through disrupted neutral lipid recycle in Saccharomyces cerevisiae. Metab Eng. 2015;28:54–62. doi:10.1016/j.ymben.2014.11.006.
   PubMed Web of Science ®Google Scholar
• Black PN, DiRusso CC. Yeast acyl-CoA synthetases at the crossroads of fatty acid metabolism and regulation. Biochim Biophys Acta. 2007;1771(3):286–298. doi:https://doi.org/10.1016/j.bbalip.2006.05.003.
   PubMed Web of Science ®Google Scholar
• Scharnewski M, Pongdontri P, Mora G, Hoppert M, Fulda M. Mutants of Saccharomyces cerevisiae deficient in acyl-CoA synthetases secrete fatty acids due to interrupted fatty acid recycling. FEBS J. 2008;275:2765–2778. doi:10.1111/j.1742-4658.2008.06417.x.
   PubMed Web of Science ®Google Scholar
• Park S-Y, Rao C, Coyte KZ, Kuziel GA, Zhang Y, Huang W, Franzosa EA, Weng J-K, Huttenhower C, Rakoff-Nahoum S. et al. Strain-level fitness in the gut microbiome is an emergent property of glycans and a single metabolite. Cell. 2022;185(3):513–29.e21. doi:10.1016/j.cell.2022.01.002.
   PubMed Web of Science ®Google Scholar
• Dou X, Gao N, Yan D, Shan A. Sodium butyrate alleviates mouse colitis by regulating gut microbiota dysbiosis. Anim (Basel). 2020;10(7):10. doi:https://doi.org/10.3390/ani10071154.
   Google Scholar
• Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27(2):104–119. doi:https://doi.org/10.1111/j.1365-2036.2007.03562.x.
   PubMed Web of Science ®Google Scholar
• Li L, Abou-Samra E, Ning Z, Zhang X, Mayne J, Wang J, Cheng K, Walker K, Stintzi A, Figeys D. et al. An in vitro model maintaining taxon-specific functional activities of the gut microbiome. Nat Commun. 2019;10(1):4146. doi:https://doi.org/10.1038/s41467-019-12087-8.
   PubMed Web of Science ®Google Scholar
• Lamas B, Richard ML, Leducq V, Pham H-P, Michel M-L, Da Costa G, Bridonneau C, Jegou S, Hoffmann TW, Natividad JM. et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med. 2016;22(6):598–605. doi:https://doi.org/10.1038/nm.4102.
   PubMed Web of Science ®Google Scholar
• Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, Belzer C, Delgado Palacio S, Arboleya Montes S, Mancabelli L. et al. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev. 2017;81(4):81. doi:https://doi.org/10.1128/mmbr.00036-17.
   Web of Science ®Google Scholar
• Jakubczyk D, Leszczyńska K, Górska S. The effectiveness of probiotics in the treatment of inflammatory bowel disease (IBD)—A critical review. Nutrients. 2020;12(7):1973. doi:10.3390/nu12071973.
   PubMed Web of Science ®Google Scholar
• Iyer N, Williams MA, O’Callaghan AA, Dempsey E, Cabrera-Rubio R, Raverdeau M, Crispie F, Cotter PD, Corr SC. Lactobacillus salivarius UCC118™ dampens inflammation and promotes microbiota recovery to provide therapeutic benefit in a DSS-Induced colitis model. Microorganisms. 2022;10(7):10. doi:https://doi.org/10.3390/microorganisms10071383.
   Web of Science ®Google Scholar
• Humen MA, De Antoni GL, Benyacoub J, Costas ME, Cardozo MI, Kozubsky L, Saudan K-Y, Boenzli-Bruand A, Blum S, Schiffrin EJ. et al. Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo. Infect Immun. 2005;73(2):1265–1269. doi:https://doi.org/10.1128/iai.73.2.1265-1269.2005.
   PubMed Web of Science ®Google Scholar
• La Ragione RM, Narbad A, Gasson MJ, Woodward MJ. In vivo characterization of lactobacillus johnsonii FI9785 for use as a defined competitive exclusion agent against bacterial pathogens in poultry. Lett Appl Microbiol. 2004;38(3):197–205. doi:https://doi.org/10.1111/j.1472-765x.2004.01474.x.
   PubMed Web of Science ®Google Scholar
• Santos Rocha C, Gomes-Santos AC, Garcias Moreira T, de Azevedo M, Diniz Luerce T, Mariadassou M, de Azevedo M, Longaray Delamare AP, Langella P, Maguin E. et al. Local and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium Lactobacillus delbrueckii. PloS One. 2014;9(1):e85923. doi:https://doi.org/10.1371/journal.pone.0085923.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017;46(4):562–576. doi:https://doi.org/10.1016/j.immuni.2017.04.008.
   PubMed Web of Science ®Google Scholar
• Fu W, Chen C, Xie Q, Gu S, Tao S, Xue W. Pediococcus acidilactici strain alleviates gluten-induced food allergy and regulates gut microbiota in mice. Front Cell Infect Microbiol. 2022;12:845142. doi:10.3389/fcimb.2022.845142.
   PubMed Web of Science ®Google Scholar
• Lorén V, Manyé J, Fuentes MC, Cabré E, Ojanguren I, Espadaler J. Comparative effect of the I3.1 probiotic formula in two animal models of colitis. Probiotics Antimicrob Proteins. 2017;9(1):71–80. doi:https://doi.org/10.1007/s12602-016-9239-5.
   PubMed Web of Science ®Google Scholar
• Holzapfel W, Arini A, Aeschbacher M, Coppolecchia R, Pot B. Enterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics. Benef Microbes. 2018;9(3):375–388. doi:https://doi.org/10.3920/bm2017.0148.
   PubMed Web of Science ®Google Scholar
• Han M, Gao T, Liu G, Zhu C, Zhang T, Sun M, Li J, Ji F, Si Q, Jiang Q. et al. The effect of a polystyrene nanoplastic on the intestinal microbes and oxidative stress defense of the freshwater crayfish, procambarus clarkii. Sci Total Environ. 2022;833:155722. doi:10.1016/j.scitotenv.2022.155722.
   PubMed Web of Science ®Google Scholar
• Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, Cohen RD, Chambers CD, Sandborn WJ. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology. 2021;160(4):1131–1139. doi:https://doi.org/10.1053/j.gastro.2020.11.038.
   PubMed Web of Science ®Google Scholar
• Louis P, Hold G, Flint H. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–672. doi:10.1038/nrmicro3344.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang J, He T, Becker S, Zhang G, Li D, Ma X. Butyrate: a double-edged sword for health? Adv Nutr. 2018;9(1):21–29. doi:https://doi.org/10.1093/advances/nmx009.
   PubMed Web of Science ®Google Scholar
• Deleu S, Machiels K, Raes J, Verbeke K, Vermeire S. Short chain fatty acids and its producing organisms: an overlooked therapy for IBD? EBioMedicine. 2021;66:66. doi:https://doi.org/10.1016/j.ebiom.2021.103293.
   Web of Science ®Google Scholar
• Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:https://doi.org/10.1016/j.cell.2016.05.041.
   PubMed Web of Science ®Google Scholar
• Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–672. doi:https://doi.org/10.1038/nrmicro3344.
   PubMed Web of Science ®Google Scholar
• Lee YS, Kim TY, Kim Y, Lee SH, Kim S, Kang SW, Yang, J-Y, Baek, I-J, Sung, YH, Park, Y-Y, et al. Microbiota-derived lactate accelerates intestinal stem-cell-mediated epithelial development. Cell Host Microbe. 2018;24:833±. doi:10.1016/j.chom.2018.11.002.
   Web of Science ®Google Scholar
• Yang XQ, Yu DK, Xue L, Li H, Du JR. Probiotics modulate the microbiota–gut–brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B. 2020;10(3):475–487. doi:10.1016/j.apsb.2019.07.001.
   PubMed Web of Science ®Google Scholar
• Lee J, d’Aigle J, Atadja L, Quaicoe V, Honarpisheh P, Ganesh BP, Hassan A, Graf J, Petrosino J, Putluri N. et al. Gut microbiota–derived short-chain fatty acids promote poststroke recovery in aged mice. Circ Res. 2020;127(4):453–465. doi:10.1161/circresaha.119.316448.
   PubMed Web of Science ®Google Scholar
• Hu J, Lin S, Zheng B, Cheung PCK. Short-chain fatty acids in control of energy metabolism. Crit Rev Food Sci Nutr. 2018;58:1243–1249. doi:10.1080/10408398.2016.1245650.
   PubMed Web of Science ®Google Scholar
• Li Z, Yi CX, Katiraei S, Kooijman S, Zhou E, Chung CK, Gao Y, van den Heuvel JK, Meijer OC, Berbée JFP. et al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut. 2018;67(7):1269–1279. doi:https://doi.org/10.1136/gutjnl-2017-314050.
   PubMed Web of Science ®Google Scholar
• Aggarwal N, Breedon AME, Davis CM, Hwang IY, Chang MW. Engineering probiotics for therapeutic applications: recent examples and translational outlook. Curr Opin Biotechnol. 2020;65:171–9. doi:10.1016/j.copbio.2020.02.016.
   PubMed Web of Science ®Google Scholar
• Hwang IY, Koh E, Wong A, March JC, Bentley WE, Lee YS, Chang MW. Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nat Commun. 2017;8(1):15028. doi:https://doi.org/10.1038/ncomms15028.
   PubMedGoogle Scholar
• McKay R, Ghodasra M, Schardt J, Quan D, Pottash AE, Shang W, Jay, SM, Payne, GF, Chang, MW, March, JC et al. A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: toward applications for Crohn’s disease. Bioeng Transl Med. 2018;3:209–221. doi:10.1002/btm2.10113.
   PubMed Web of Science ®Google Scholar
• Wu L, Han Y, Zheng Z, Peng G, Liu P, Yue S, Zhu S, Chen J, Lv H, Shao L. et al. Altered gut microbial metabolites in amnestic mild cognitive impairment and Alzheimer’s disease: signals in host–microbe interplay. Nutrients. 2021;13(1):13. doi:10.3390/nu13010228.
   Web of Science ®Google Scholar
• Bai Y, Mansell TJ. Production and sensing of butyrate in a probiotic E. coli strain. Int J Mol Sci. 2020;21(10):3615. doi:10.3390/ijms21103615.
   PubMed Web of Science ®Google Scholar
• Dang Z, Gao M, Wang L, Wu J, Guo Y, Zhu Z, Huang H, Kang G. Synthetic bacterial therapies for intestinal diseases based on quorum-sensing circuits. Biotechnol Adv. 2023;65:108142. doi:10.1016/j.biotechadv.2023.108142.
   PubMed Web of Science ®Google Scholar
• Sann H, Erichsen J, Hessmann M, Pahl A, Hoffmeyer A. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice. Life Sci. 2013;92:708–718. doi:10.1016/j.lfs.2013.01.028.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar